We anticipate that the elevated expression of these phosphatases in patients with MDS could lead to the functional inactivation of PI3K/AKT signaling in HSCs, which could contribute to impaired HSC differentiation and genomic instability via impaired autophagy. The gene discussed is AKT1; the disease is myelodysplastic syndrome.